German CLL Study Group

1:20
Inside the German CLL Study Group’s annual workshop
Barbara Eichhorst
1:08
The 2016 International Workshop of the German CLL Study Group (GCLLSG)
Michael Hallek
2:24
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
John Gribben
1:25
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting
Barbara Eichhorst
4:54
How combining an evolutionary perspective with genomic methods can advance CLL treatment
Dan Landau
1:11
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
Stephan Stilgenbauer
3:11
Highlights from the International Workshop of the German CLL Study Group
Michael Hallek
2:41
How to overcome resistance to new compounds in CLL
Arnon Kater
2:16
How to treat a previously treated CLL patient
Carsten Niemann
4:04
The discovery and role of BCL2 and microRNA in CLL
Carlo Croce
1:10
Changes in research to overcome the problem of resistance to new CLL drugs
Arnon Kater
2:50
iwCLL 2017 program: the biology of CLL, treatment options and the relapsed/refractory setting
Nicholas Chiorazzi
3:28
The importance of the life cycle of CLL cells and how it can inform treatment
Nicholas Chiorazzi
1:33
An overview of iwCLL 2017 meeting in New York by Prof. Michael Hallek
Michael Hallek
5:30
Targeting ROR1 and a two-drug approach to cure CLL
Carlo Croce
4:30
How the removal of macrophages from tissue can stop or slow down the progression of CLL
Federico Caligaris-Cappio
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals